Wutah pendapatan YoY sajrone 12 wulan kepungkur: Tempest Therapeutics (TPST)

Tempest Therapeutics relies on stable medical demand, remaining insulated from macroeconomic downturns. Year-over-year sales dynamics for the last 12 months TTM on GURU.Markets are available for analysis, where 0.00 represents the current level of the metric. Tempest Therapeutics is developing a unique immune activation platform, yet faces intense pressure from resource-rich pharma behemoths amid high scientific risks.
Tempest Therapeutics - rincian analitis lan metrik utama (TPST)

This indicator measures the percentage change in trailing twelve-month revenue, smoothing out seasonal fluctuations to assess the actual pace of business expansion. For Tempest Therapeutics (TPST), this metric reflects the commercial efficiency of diversifying its oncology portfolio and penetrating the liver and colorectal cancer therapy markets. By analyzing the trailing twelve-month revenue change chart, an investor can compare actual growth against stated risks. Sharp spikes in values warrant caution due to the probability of a subsequent correction. A stable positive trend confirms the resilience of the company's fundamental development model.